-
of the post will involve synthesis and manufacture of prototype viral vectors, as well as testing their ability to treat experimental disease models, in vivo and in vitro. Other The advert will close on 05
-
, will address the development of one of the vaccine technologies developed within the Hub in collaboration with other PDRAs, namely viral vectored vaccines, glycoconjugates, sub-unit/VLPs and mRNA
-
verification and assurance options, Specifically, the role will involve investigating: Excessive Agency and discovery of data and other misconfigured attack vectors an AI system can exploit. Misuse, by analysing
-
Project: Novel GM interventions for mosquito control could represent a step change in progressing towards elimination of the world’s most harmful vector-borne diseases, including malaria and dengue. However
-
looking at the design and analysis of randomised trials of interventions to reduce the risk of vector-borne diseases (e.g. malaria and dengue). The Project offers an interdisciplinary opportunity to work in
-
of schistosomiasis across rural-to-urban settings and develop tools to support targeted interventions. A key focus will be on mapping snail vector distribution near expanding water infrastructure (e.g., sand dams) in
-
methodology project looking at the design and analysis of randomised trials of interventions to reduce the risk of vector-borne diseases (e.g. malaria and dengue). The Project offers an interdisciplinary
-
transmission risk. This will include investigating the distribution and abundance of snail vectors of schistosomiasis along the increasing number of water management infrastructure (e.g. sand dams) in Kenya, and
-
translated eleven vaccine candidates, including viral vectors, recombinant proteins-in-adjuvants and a virus-like particle, into Phase 1 and 2 clinical trials in the UK and Africa. Over half of these trials